Granulocyte–Macrophage Colony-Stimulating Factor (GM-CSF)-secreting allogeneic pancreatic tumor cell (GVAX) immunotherapy consists of two irradiated human allogeneic pancreatic tumor cell lines (CG8020/CG2505) that underwent modification to enable the secretion of GM-CSF (NCT00389610). This evidence concerns the gene CSF2 and pancreatic neoplasm.